Arch Biopartners Inc

(ACHFF, OTCQB)

$1.00

+$0.00
(+0.00%)
PE Ratio
0.00
EPS
-$0.04
Market Cap
$60M
52 Week Range
$0.53 - $1.15
Operating Margin
0.00%
Dividend & Yield
$0.00 (0.00%)
Volume
NaN
Rev. per Share
$0.00

About Arch Biopartners Inc

Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients. The company develops AB569, a drug candidate for the treatment of antibiotic resistant bacterial infections, primarily in the lungs and wounds, as well as to treat pseudomonas aeruginosa infections in the respiratory tracts of patients with cystic fibrosis. It also develops MetaBlok, a drug candidate for the treatment of sepsis, cancer metastasis, and inflammation based diseases. In addition, the company develops Borg, a Peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is headquartered in Toronto, Canada.

Earnings

News about Arch Biopartners Inc

Arch Biopartners Inc

Type
Sector
Healthcare
Industry
Biotechnology
About kinfo
Kinfo is an app for DIY traders and investors. Kinfo tracks your trading performance and lets you compare measurable performance metrics against other traders. Kinfo works for day trading, swing trading and longer holding periods. By tracking portfolio performance kinfo allows traders to learn, find inspiration and gain confidence.
Get Social
Download the App